Meningococcal Group B Vaccine 2024-2025 (2026, 2027)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Meningococcal Group B Vaccine belonging to the National Vaccination Programme in Finland. The contract period is about two years during 2024-2025. The procurement contains two options to extend the contract for the years 2026 and 2027. Estimated quantity for the contract period including option is 4000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. Please note that all times given in the Call for tender refer to local time in Finland. Call for tenders, annexes: Annex 1 Minimum Requirements Concerning the Subject of Procurement Meningococcal Group B Vaccine for risk groups Annex 2 JYSE 2014 Supplies (updated version of April 2022) Annex 3 Handi Annex 4 Contract

The purpose of STM and the Customer is to procure Meningococcal Group B Vaccine required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for adults, children and infants. More information about National Vaccination Programme and vaccinations can be found on the website of the National Institute for Health and Welfare: https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/meningococcal-vaccines/meningococcus-b-vaccine The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. CONTRACT PERIOD The contract´s duration is about two years. Estimated quantity for the contract period is 2000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The Contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. After the contract period, the Customer reserves the right for the option described in section "Description of renewals". Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tender.

Tenderers may ask clarification questions using the Supplier Portal. The questions must be in English and will be answered in English. To guarantee the equal treatment of tenderers, questions posed in any other way cannot be answered. All times given in the Call for tender refer to local time in Finland.

This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the Hilma electronic procurement portal at www.hankintailmoitukset.fi as well as in this Call for Tenders and its Annexes.